Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells.
[lymphangioleiomyomatosis]
The
mammalian
/
mechanistic
target
of
rapamycin
complex
1
(
mTORC
1
)
signaling
pathway
is
hyperactivated
in
a
variety
of
cancers
and
disorders
,
including
lymphangioleiomyomatosis
(
LAM
)
and
tuberous
sclerosis
complex
(
TSC
)
,
which
are
characterized
by
mutations
in
tumor
suppressors
TSC
1
or
TSC
2
.
The
concern
with
the
use
of
mTORC
1
inhibitors
,
such
as
rapamycin
or
its
analogs
(
rapalogs
)
,
is
that
they
cause
upregulation
of
autophagy
and
suppress
the
negative
feedback
loop
to
Akt
,
which
promotes
cell
survival
,
causing
the
therapy
to
be
only
partially
effective
,
and
relapse
occurs
upon
cessation
of
treatment
.
In
this
study
,
we
investigate
the
use
of
rapamycin
in
combination
with
resveratrol
,
a
naturally
occurring
polyphenol
,
in
TSC
2
-
deficient
cells
.
We
tested
whether
such
combination
would
prevent
rapamycin-induced
upregulation
of
autophagy
and
shift
the
cell
fate
toward
apoptosis
.
We
found
that
this
combination
treatment
blocked
rapamycin-induced
upregulation
of
autophagy
and
restored
inhibition
of
Akt
.
Interestingly
,
the
combination
of
rapamycin
and
resveratrol
selectively
promoted
apoptosis
of
TSC
2
-
deficient
cells
.
Thus
,
the
addition
of
resveratrol
to
rapamycin
treatment
may
be
a
promising
option
for
selective
and
targeted
therapy
for
diseases
with
TSC
loss
and
mTORC
1
hyperactivation
.
Diseases
Validation
Diseases presenting
"tumor suppressors"
symptom
cholangiocarcinoma
dedifferentiated liposarcoma
esophageal adenocarcinoma
esophageal squamous cell carcinoma
lymphangioleiomyomatosis
werner syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom